Jennifer Green

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Justin F. Gainor, Giuseppe Curigliano, Dong‐Wan Kim et al. · The Lancet Oncology · 2021 · 443 citations · Full text

Medicine, Molecular Medicine, Oncology +12

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Vivek Subbiah, Philippe A. Cassier, Salvatore Siena et al. · Nature Medicine · 2022 · 239 citations · Full text

Medicine, Oncology, Pharmacology +16

Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III

R. Beverly Raney, Lina Asmar, Rena Vassilopoulou‐Sellin et al. · Medical and Pediatric Oncology · 1999 · 182 citations

Medicine, Oncology, Radiation Oncology +11

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

Elvira Isganaitis, Dan Raghinaru, Louise Ambler-Osborn et al. · Diabetes Technology & Therapeutics · 2020 · 111 citations · Full text

Medicine, Endocrinology, Pediatrics +17

Primary and metastatic rhabdomyosarcoma in the breast: Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study

Daniel M. Hays, Sarah S. Donaldson, Hiroyuki Shimada et al. · Medical and Pediatric Oncology · 1997 · 108 citations

Medicine, Oncology, Surgery +12